96 related articles for article (PubMed ID: 22342610)
21. Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
Lee MS; Cho JY; Kim SY; Cheon GJ; Moon MH; Oh S; Lee J; Lee S; Woo S; Kim SH
J Magn Reson Imaging; 2017 Feb; 45(2):597-609. PubMed ID: 27586519
[TBL] [Abstract][Full Text] [Related]
22. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
23. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
24. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
[TBL] [Abstract][Full Text] [Related]
25. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
Qu X; Huang X; Yan W; Wu L; Dai K
Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
[TBL] [Abstract][Full Text] [Related]
26. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
27. 11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.
Mena E; Turkbey B; Mani H; Adler S; Valera VA; Bernardo M; Shah V; Pohida T; McKinney Y; Kwarteng G; Daar D; Lindenberg ML; Eclarinal P; Wade R; Linehan WM; Merino MJ; Pinto PA; Choyke PL; Kurdziel KA
J Nucl Med; 2012 Apr; 53(4):538-45. PubMed ID: 22343504
[TBL] [Abstract][Full Text] [Related]
28. 11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer.
Wachter S; Tomek S; Kurtaran A; Wachter-Gerstner N; Djavan B; Becherer A; Mitterhauser M; Dobrozemsky G; Li S; Pötter R; Dudczak R; Kletter K
J Clin Oncol; 2006 Jun; 24(16):2513-9. PubMed ID: 16636343
[TBL] [Abstract][Full Text] [Related]
29. (11)C-acetate PET in the early evaluation of prostate cancer recurrence.
Albrecht S; Buchegger F; Soloviev D; Zaidi H; Vees H; Khan HG; Keller A; Bischof Delaloye A; Ratib O; Miralbell R
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):185-96. PubMed ID: 16832632
[TBL] [Abstract][Full Text] [Related]
30. Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer.
Polanec SH; Andrzejewski P; Baltzer PAT; Helbich TH; Stiglbauer A; Georg D; Karanikas G; Susani M; Wadsak W; Margreiter M; Mitterhauser M; Brader P; Pinker K
PLoS One; 2017; 12(7):e0180790. PubMed ID: 28719629
[TBL] [Abstract][Full Text] [Related]
31. Fully automated deformable registration of breast DCE-MRI and PET/CT.
Dmitriev ID; Loo CE; Vogel WV; Pengel KE; Gilhuijs KG
Phys Med Biol; 2013 Feb; 58(4):1221-33. PubMed ID: 23369926
[TBL] [Abstract][Full Text] [Related]
32. [PET and PET/CT in relapsing prostate carcinoma].
Reske SN; Blumstein NM; Glatting G
Urologe A; 2006 Oct; 45(10):1240, 1242-4, 1246-8, 1250. PubMed ID: 17006698
[TBL] [Abstract][Full Text] [Related]
33.
Salminen A; Jambor I; Merisaari H; Ettala O; Virtanen J; Koskinen I; Veskimae E; Sairanen J; Taimen P; Kemppainen J; Minn H; Boström PJ
Cancer Imaging; 2018 Aug; 18(1):25. PubMed ID: 30068379
[TBL] [Abstract][Full Text] [Related]
34. Acute diverticulitis is positive in 11C-acetate PET/CT.
Blum S; Pannach S; Brogsitter C; Abolmaali N; Zöphel K
Nuklearmedizin; 2014 Aug; 53(4):N33-4. PubMed ID: 25100558
[No Abstract] [Full Text] [Related]
35. Real-time sonoelastography compared to magnetic resonance imaging using four different modalities at 3.0 T in the detection of prostate cancer: strength and weaknesses.
Pelzer AE; Heinzelbecker J; Weiß C; Frühbauer D; Weidner AM; Kirchner M; Stroebel P; Schoenberg SO; Dinter DJ
Eur J Radiol; 2013 May; 82(5):814-21. PubMed ID: 23273821
[TBL] [Abstract][Full Text] [Related]
36. 11C/ 18F-choline PET or 11C/18F-acetate PET in prostate cancer: may a choice be recommended?
Nanni C; Castellucci P; Farsad M; Rubello D; Fanti S
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1704-5. PubMed ID: 17619877
[No Abstract] [Full Text] [Related]
37. Evaluation of Prostate Cancer with 11C-Acetate PET/CT.
Spick C; Herrmann K; Czernin J
J Nucl Med; 2016 Oct; 57(Suppl 3):30S-37S. PubMed ID: 27694168
[TBL] [Abstract][Full Text] [Related]
38. Prostate Cancer Metastases to Inguinal Lymph Nodes Detected by Attenuation-Corrected 11C-Acetate PET/CT.
Shah VA; Rixey A; Dusing R
J Nucl Med Technol; 2016 Mar; 44(1):46-8. PubMed ID: 26111708
[TBL] [Abstract][Full Text] [Related]
39. [Imaging diagnostics of advanced prostate cancer].
Kretschmer A; Seitz M; Graser A; Stief CG; Tilki D
Urologe A; 2013 Apr; 52(4):497-503. PubMed ID: 23483268
[TBL] [Abstract][Full Text] [Related]
40. PET imaging with 11C-acetate in prostate cancer: a biochemical, radiochemical and clinical perspective.
Soloviev D; Fini A; Chierichetti F; Al-Nahhas A; Rubello D
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):942-9. PubMed ID: 18338167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
